Rheumatology
| Epidemiology
Rheumatology
Epidemiology

Preliminary predictive criteria for COVID-19 cytokine storm

book_2 Source: Ann Rheum Dis 2021;80:88-95.
calendar_today Published on Medfyle: March 2021
import_contacts 7 min
headphones 5 min

In this medfyle

COVID-CS predicts longer hospitalization and increased mortality, and requires specific treatment.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Expert commentary

David S. Pisetsky, MD, PhD

Professor of Medicine and Immunology
Duke University Medical Center
Durham, NC USA

About this Medfyle
Read more arrow_downward Hide arrow_upward

This Medfyle is provided as a service to healthcare professionals. It has been created from content originally published in the Annals of the Rheumatic Diseases, EULAR’s official journal, through an official agreement with BMJ. 

The summary content was prepared by Marie Farrow for Medfyle, reviewed & approved by David S. Pisetsky, MD, PhD, Duke University Medical Center, Durham, NC USA.

Original article:
Caricchio R, Gallucci M, Dass C Temple University COVID-19 Research Group, et al. Preliminary predictive criteria for COVID-19 cytokine stormAnnals of the Rheumatic Diseases 2021;80:88-95.
The authors of the original article had no part in the creation of the summary.

 

Copyright © 2020 BMJ Publishing Group Limited and Globalport (International) Limited. All rights reserved.
The summaries, expert commentaries and slides included in this Medfyle are co-owned by BMJ and GlobalPort  (International) Limited. The original journal article is an exclusive copyright of BMJ Publishing Group Limited.


Feedback